These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33052479)

  • 1. Neuroinflammatory responses in Parkinson's disease: relevance of Ibuprofen in therapeutics.
    Singh A; Tripathi P; Singh S
    Inflammopharmacology; 2021 Feb; 29(1):5-14. PubMed ID: 33052479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets.
    Corwin C; Nikolopoulou A; Pan AL; Nunez-Santos M; Vallabhajosula S; Serrano P; Babich J; Figueiredo-Pereira ME
    J Neuroinflammation; 2018 Sep; 15(1):272. PubMed ID: 30236122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic neurotoxicity by 6-OHDA and MPP+: differential requirement for neuronal cyclooxygenase activity.
    Carrasco E; Casper D; Werner P
    J Neurosci Res; 2005 Jul; 81(1):121-31. PubMed ID: 15931668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential neuroprotective effect of ibuprofen, insights from the mice model of Parkinson's disease.
    Swiątkiewicz M; Zaremba M; Joniec I; Członkowski A; Kurkowska-Jastrzębska I
    Pharmacol Rep; 2013; 65(5):1227-36. PubMed ID: 24399718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review).
    Harris RE; Beebe-Donk J; Doss H; Burr Doss D
    Oncol Rep; 2005 Apr; 13(4):559-83. PubMed ID: 15756426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibuprofen or piroxicam protects nigral neurons and delays the development of l-dopa induced dyskinesia in rats with experimental Parkinsonism: Influence on angiogenesis.
    Teema AM; Zaitone SA; Moustafa YM
    Neuropharmacology; 2016 Aug; 107():432-450. PubMed ID: 27016022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinflammatory processes in Parkinson's disease.
    Hunot S; Hirsch EC
    Ann Neurol; 2003; 53 Suppl 3():S49-58; discussion S58-60. PubMed ID: 12666098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-steroidal anti-inflammatory drugs in Parkinson's disease.
    Esposito E; Di Matteo V; Benigno A; Pierucci M; Crescimanno G; Di Giovanni G
    Exp Neurol; 2007 Jun; 205(2):295-312. PubMed ID: 17433296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibuprofen and Alzheimer's disease.
    Dokmeci D
    Folia Med (Plovdiv); 2004; 46(2):5-10. PubMed ID: 15506544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
    Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE
    Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of non-steroidal anti-inflammatory drugs on prostaglandin E2 production by cyclooxygenase-2 from endogenous and exogenous arachidonic acid in rat peritoneal macrophages stimulated with lipopolysaccharide.
    Nakatsugi S; Sugimoto N; Furukawa M
    Prostaglandins Leukot Essent Fatty Acids; 1996 Dec; 55(6):451-7. PubMed ID: 9014225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin.
    Jaradat MS; Wongsud B; Phornchirasilp S; Rangwala SM; Shams G; Sutton M; Romstedt KJ; Noonan DJ; Feller DR
    Biochem Pharmacol; 2001 Dec; 62(12):1587-95. PubMed ID: 11755111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroinflammatory Responses and Parkinson' Disease: Pathogenic Mechanisms and Therapeutic Targets.
    Yang L; Mao K; Yu H; Chen J
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):830-837. PubMed ID: 32529463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidating the Neuroprotective Role of PPARs in Parkinson's Disease: A Neoteric and Prospective Target.
    Behl T; Madaan P; Sehgal A; Singh S; Sharma N; Bhatia S; Al-Harrasi A; Chigurupati S; Alrashdi I; Bungau SG
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
    Pasinetti GM
    J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant roles of neuroinflammation in Parkinson's disease: therapeutic targets for PD prevention.
    Lee Y; Lee S; Chang SC; Lee J
    Arch Pharm Res; 2019 May; 42(5):416-425. PubMed ID: 30830660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic Pharmacological Characterization of EV-34, a New H
    Gyöngyösi A; Verner V; Bereczki I; Kiss-Szikszai A; Zilinyi R; Tósaki Á; Bak I; Borbás A; Herczegh P; Lekli I
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33498831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone.
    Javed H; Azimullah S; Abul Khair SB; Ojha S; Haque ME
    BMC Neurosci; 2016 Aug; 17(1):58. PubMed ID: 27549180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuron-Astrocyte Interactions in Parkinson's Disease.
    Miyazaki I; Asanuma M
    Cells; 2020 Dec; 9(12):. PubMed ID: 33297340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinflammation in Parkinson's disease.
    Hirsch EC; Vyas S; Hunot S
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S210-2. PubMed ID: 22166438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.